<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="available that reference secondary infections showed that most clinicians prescribed" exact="meropenem" post="and linezolid to children with a rate of prophylactic"/>
 <result pre="reference secondary infections showed that most clinicians prescribed meropenem and" exact="linezolid" post="to children with a rate of prophylactic treatment between"/>
 <result pre="type of antibiotics used. The most commonly used antibiotics were" exact="moxifloxacin" post="(n = 452, 39.2%) and azithromycin (n = 294,"/>
 <result pre="commonly used antibiotics were moxifloxacin (n = 452, 39.2%) and" exact="azithromycin" post="(n = 294, 30.7%). Others include ceftriaxone, vancomycin, cefepime,"/>
 <result pre="maxipime, azithromycin, amoxicillin-clavulanate, cefoperazone/sulbactam, quinolone plus azithromycin, levofloxacin, moxifloxacin, and" exact="ceftriaxone" post="plus azithromycin, and most commonly azithromycin (n = 206,"/>
 <result pre="azithromycin, levofloxacin, moxifloxacin, and ceftriaxone plus azithromycin, and most commonly" exact="azithromycin" post="(n = 206, 74.6%). Of the four studies that"/>
 <result pre="was reported in three studies, administering amoxicillin-clavulanate, clarithromycin, azithromycin, levofloxacin," exact="moxifloxacin" post="and ceftriaxone plus azithromycin (47, 49, 51). In total,"/>
 <result pre="in three studies, administering amoxicillin-clavulanate, clarithromycin, azithromycin, levofloxacin, moxifloxacin and" exact="ceftriaxone" post="plus azithromycin (47, 49, 51). In total, 12 patients"/>
 <result pre="studies, administering amoxicillin-clavulanate, clarithromycin, azithromycin, levofloxacin, moxifloxacin and ceftriaxone plus" exact="azithromycin" post="(47, 49, 51). In total, 12 patients out of"/>
 <result pre="Sixty eight patients were treated with the antibiotics piperacillin-tazobactam, azithromycin," exact="ceftriaxone" post="and trimethoprim- sulfamethoxazole, levofloxacin, imipenem and other broad-spectrum antibiotics"/>
 <result pre="with the antibiotics piperacillin-tazobactam, azithromycin, ceftriaxone and trimethoprim- sulfamethoxazole, levofloxacin," exact="imipenem" post="and other broad-spectrum antibiotics (55, 56, 58, 59). The"/>
 <result pre="(96.6%) (65â€“67, 71, 72). The most commonly used antibiotics were" exact="vancomycin" post="(n = 317, 46.2%) and imipenem/meropenem (n = 243,"/>
 <result pre="= 243, 54.7%). Others were azithromycin, ceftriaxone, cephalosporin, piperacillin-tazobactam, linezolid," exact="vancomycin" post="plus cefepime, vancomycin plus meropenem, clarithromycin, levofloxacin and dicloxacillin."/>
 <result pre="Others were azithromycin, ceftriaxone, cephalosporin, piperacillin-tazobactam, linezolid, vancomycin plus cefepime," exact="vancomycin" post="plus meropenem, clarithromycin, levofloxacin and dicloxacillin. In total, 223"/>
 <result pre="cephalosporin, piperacillin-tazobactam, linezolid, vancomycin plus cefepime, vancomycin plus meropenem, clarithromycin," exact="levofloxacin" post="and dicloxacillin. In total, 223 patients of 910 (24.5%)"/>
 <result pre="one of the studies reported the use of azithromycin, vancomycin," exact="ceftriaxone" post="and cephalosporin (65). In general, all eight case studies"/>
 <result pre="study. Clin Infect Dis. (2020) 29:ciaa19910.1093/cid/ciaa199 35.GautretPLagierJCParolaPMeddebLMailheMDoudierBet al.. Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
</results>
